Molecular biological detection method of azole-based antifungal medicine resistant trichophyton indotineae
A nucleic acid amplification method using specific primers for CYP51B gene regions allows rapid and economical differentiation of Trichophyton indotineae strains' resistance to azole antifungal drugs by analyzing LA-PCR products, overcoming the limitations of expensive sequencing methods.
Patent Information
- Application Number
- JP2023077076
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-05-09
- Publication Date
- 2024-11-21
AI Technical Summary
There is a need for a cheaper and faster method to differentiate susceptible and resistant strains of Trichophyton indotineae to azole antifungal drugs, as existing methods rely on expensive next-generation sequencing for determining the number of CYP51B gene copies.
A nucleic acid amplification method using specific primers targeting the CYP51B gene regions, followed by agarose gel electrophoresis to estimate the number of gene copies, allowing differentiation between susceptible and resistant strains.
Enables quick and cost-effective differentiation of azole antifungal-resistant strains by analyzing the size of LA-PCR amplified products, eliminating the need for expensive next-generation sequencing.
Smart Images

Figure 2024161970000002 
Figure 2024161970000003 
Figure 2024161970000001
Abstract
Description
[Technical field]
[0001] The present invention relates to a molecular biological method for detecting azole antifungal drug-resistant Trichophyton indotineae. [Background technology]
[0002] In 2018, numerous outbreaks of tinea corporis were reported in India, showing resistance (low susceptibility) to the arylamine antifungal drug terbinafine (TBF), and the causative agent was determined to be Trichophyton interdigitale. In 2020, the TBF-resistant T. interdigitale was proposed as a new species, Trichophyton indotineae, by Kano et al. (Non-Patent Document 1).
[0003] In 2022, the inventors reported that resistance to azole antifungals (itraconazole, voriconazole) in T. indotineae is based on overexpression of the CYP51B gene (TinCYP51B) due to an increase in the copy number of the gene (Non-patent Document 2). [Prior art documents] [Non-patent literature]
[0004] [Non-Patent Document 1] Kano, R. et al., Trichophyton indotineae sp. nov.: A New Highly Terbinafine-Resistant Anthropophilic Dermatophyte Species. Mycopathologia 185, 947-958 (2020). [Non-Patent Document 2] Yamada, T. et al., Gene Amplification of CYP51B: a New Mechanism of Resistance to Azole Compounds in Trichophyton indotineae. Antimicrobial Agents and Chemotherapy June 2022 Volume 66 Issue 6. Summary of the Invention [Problem to be solved by the invention]
[0005] In Non-Patent Document 2, the copy number of the CYP51B gene was determined by determining the whole genome sequence of T. indotineae using a next-generation sequencer, and a cheaper and quicker method for distinguishing between susceptible and resistant strains was desired. [Means for solving the problem]
[0006] The above problems can be solved by the present invention as follows: [1] preparing a genomic DNA sample from the tinea fungus Trichophyton indotineae (T. indotineae); a step of performing a nucleic acid amplification reaction of the nucleic acid sample using a combination of a forward primer containing a base sequence complementary to an antisense strand upstream from the 5' end of the translation region of the CYP51B gene of T. indotineae and a reverse primer containing a base sequence complementary to a sense strand downstream from the 3' end of the translation region of the CYP51B gene, and analyzing the size of the obtained nucleic acid amplification product to predict the number of duplicated copies of the CYP51B gene in T. indotineae and determine resistance to an azole antifungal agent; Including, A method for identifying azole antifungal drug-resistant strains of T. indotineae. Effect of the Invention
[0007] According to the present invention, it is possible to more inexpensively and quickly distinguish between strains of T. indotineae that are sensitive to azole antifungal drugs and those that are resistant to them. [Brief description of the drawings]
[0008] [Figure 1] FIG. 1 is an explanatory diagram showing the number and arrangement of CYP51B genes (TinCYP51B) on the genome of T. indotineae azole antifungal drug-susceptible (TIMM20114) and azole antifungal drug-resistant strains (TIMM20116, TIMM20118). [Diagram 2] This is an electrophoretic image showing the results of agarose gel electrophoresis of the PCR amplified products (DNA fragments) obtained by performing LA-PCR (Long and accurate PCR) using a combination of the sense primer of sequence number 1 and the antisense primer of sequence number 2, and genomic DNA samples extracted from an azole antifungal drug-resistant strain and an azole antifungal drug-sensitive strain of T. indotineae as templates. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0009] As shown in Figure 1 and Table 1, in azole antifungal drug-susceptible strains of T. indotineae (hereinafter sometimes simply referred to as susceptible strains), the copy number of TinCYP51B is 1, whereas in azole antifungal drug-resistant strains (hereinafter sometimes simply referred to as resistant strains), the copy number of TinCYP51B is multiple (e.g., 3 to 7), and in the resistant strains, duplicated TinCYP51B are repeated in a row in the same direction on the genome (tandem repeat structure). In the resistant strains, the copy number of TinCYP51B is increased, and therefore the gene is overexpressed, resulting in resistance to azole antifungal drugs.
[0010] In the differentiation method of the present invention, a primer set is used that is a combination of a forward primer containing a base sequence complementary to the antisense strand upstream of the 5' end of the translation region of TinCYP51B and a reverse primer containing a base sequence complementary to the sense strand downstream of the 3' end of the translation region of TinCYP51B.
[0011] The forward primer can be designed to target a region preferably from 20 to 40, more preferably from 25 to 35 in SEQ ID NO:4. The reverse primer can be designed to target a region preferably from 20 to 40, more preferably from 25 to 35, of SEQ ID NO:4.
[0012] Each step in the identification method of the present invention, such as culturing T. indotineae, preparation of genomic DNA samples, nucleic acid amplification reaction, and confirmation of nucleic acid amplification products, can be carried out according to standard methods or as described in the examples below. EXAMPLES
[0013] The present invention will be specifically described below with reference to examples, but the scope of the present invention is not limited thereto.
[0014] Example 1 In this example, genomic DNA extracted from four strains of the tinea fungus Trichophyton indotineae (T. indotineae), which are sensitive or resistant to azole antifungal agents (itraconazole, voriconazole), was used to perform LA-PCR (Long and accurate PCR) to amplify the CYP51B gene (TinCYP51B), and the correlation between the size of the obtained nucleic acid amplification product and the duplicated copy number of the CYP51B gene was examined.
[0015] For T. indotineae, the susceptible strain was TIMM20114, and the resistant strain was NUBS19006. TThe TIMM20118 and TIMM20119 strains were used (obtained from the culture collection of the Teikyo University Medical Mycology Research Center). The genomic DNA of T. indotineae was extracted by culturing it on Sabouraud glucose agar medium (1% peptone, 2% glucose, 2% agar) for 3 to 4 days, recovering the mycelium, freezing it in liquid nitrogen, and destroying the mycelium using a Multi-Beads shocker (Yasui Kikai Co., Ltd., Osaka). The mycelium was then deproteinized by treatment with phenol and chloroform, and extracted by ethanol precipitation.
[0016] The PCR primers used were a combination of a sense primer (SEQ ID NO: 1; Ticyp51B-LAS: 5'-ACAGGGGAGGAGACTTTGTTGCAATTGTGG-3') and an antisense primer (SEQ ID NO: 2; Ticyp51B-LAR: 5'-CAAACACATGGAGTACCGCCGTCAAGGTTC-3'). The target sequence of the antisense primer is shown in SEQ ID NO: 3 (5'-GAACCTTGACGGCGGTACTCCATGTGTTTG-3'). The base sequence of the TinCYP51B gene (1 copy) and its surrounding region of the sensitive strain TIMM20114 strain is shown in SEQ ID NO: 4 (total 6837 bases), and the base sequence of the TinCYP51B gene (7 copies) and its surrounding region of the resistant strain TIMM20118 strain is shown in SEQ ID NO: 5 (total 21261 bases). In SEQ ID NO: 4, the start codon ATG of the TinCYP51B gene is 2535-2537, and the stop codon TGA is 4320-4322. The sequence of SEQ ID NO:1 corresponds to 139-168 of SEQ ID NO:4 or 139-168 of SEQ ID NO:5, and the sequence of SEQ ID NO:2 corresponds to 4876-4905 of SEQ ID NO:4 or 19300-19329 of SEQ ID NO:5.
[0017] LA-PCR was carried out under the following conditions, and the resulting amplified products were subjected to electrophoresis using 0.6% agarose gel. The extracted gene (approximately 100 ng) was used as a template to prepare a reaction solution using the enzymes and buffer provided with a commercially available kit (long range PCR enzyme mix; biotechrabbit GmbH, Berlin, Germany). The composition of the reaction solution is as follows: 2.5μL 10x reaction mixture 5μL 5xPCR enhancer 1.5μL 2.5mmol / L dNTPs 0.75U enzyme 0.3μL each primer (100nmol) set Total 25μL The reaction conditions are After denaturation at 95°C for 2 min, The following cycle was repeated 30 times: 95℃, 30 seconds 68℃, 25 minutes
[0018] FIG. 2 shows the electrophoretic image of the CYP51B gene amplified products by LA-PCR. In addition, the susceptibility (MIC) of each T. indotineae strain to itraconazole (ITC) and voriconazole (VRC) was 80 The MICs, susceptibility / resistance to azole antifungal agents, and number of duplicated copies of the CYP51B gene in the genome are summarized in Table 1. 80 is the lowest concentration (unit: μg / mL) of antifungal agent present in a well that shows 80% growth inhibition compared to the absorbance value obtained without antifungal agent. The number of duplicated copies of the CYP51B gene in the genome is based on the whole genome sequence determined by next-generation sequencing.
[0019] [Table 1]
[0020] The TIMM20114 strain, which is susceptible to azole antifungal drugs, had a single duplicated copy of the CYP51B gene determined from the whole genome sequence, and the LA-PCR amplification product contained a single amplified band (Fig. 2, lane 1). T The duplicated copy numbers of the CYP51B gene in the TIMM20114 strain (lane 2 in Fig. 2), the TIMM20118 strain (lane 3 in Fig. 2), and the TIMM20119 strain (lane 4 in Fig. 2) were 3, 7, and 5 copies, respectively, and amplified bands of the same size as the TIMM20114 strain, as well as bands of a longer base length, were observed. T When comparing the amplified bands of the TIMM20118 strain (7 copies) and the TIMM20118 strain (3 copies), the NUBS19006 T A band longer than that of the strain was observed.
[0021] It is thought that resistance to azole antifungal agents is conferred depending on the copy number of the CYP51B gene. According to the present invention, the number of duplicated copies of the CYP51B gene can be predicted from the band size of the LA-PCR amplified product without determining the entire genome sequence using an expensive next-generation sequencer, and the presence or absence of resistance to azole antifungal agents can be determined by inexpensive and routine LA-PCR and the electrophoretic image of the amplified product, i.e., sensitive strains can be distinguished from resistant strains. [Industrial Applicability]
[0022] The present invention can be used to distinguish between strains of Trichophyton indotineae that are sensitive to azole antifungal agents and those that are resistant to them.
Claims
[Claim 1] Preparing a genomic DNA sample from the ringworm fungus Trichophyton indotineae (T. indotineae); A step of performing a nucleic acid amplification reaction of the nucleic acid sample using a combination of a forward primer containing a base sequence complementary to the antisense strand upstream from the 5' end of the translation region of the CYP51B gene of T. indotineae and a reverse primer containing a base sequence complementary to the sense strand downstream from the 3' end of the translation region of the CYP51B gene, and analyzing the size of the resulting nucleic acid amplification product to predict the number of duplicated copies of the CYP51B gene in T. indotineae and determine resistance to an azole antifungal agent; Including, Method for identifying azole antifungal drug resistant strains in T. indotineae.
